Decreasing antibiotic exposure in the neonatal intensive care unit
Controlling exposure to antibiotics is important for stewardship programs, and is even more important in neonatal intensive care unit. A report on a quality improvement program offers some good news.
The quest to reduce antibiotic resistance and to utilize antibiotic stewardship has been one of the biggest drives in medicine over the past decade. Research into the effect of exposure to antibiotics early in life has also led to a push to reduce the use in newborns and particularly in the neonatal intensive care unit. A report in Pediatrics offers the results of a comprehensive quality improvement run in a level 4 neonatal intensive care unit that had the goal of decreasing the antibiotic use rate by 20%.1
The investigators ran that initiative within the context a multicenter learning collaborative that was focused on reducing the unnecessary use of antibiotics. The strategies for improvement addressed the gaps seen in the core elements of antibiotic stewardship programs. Outcomes measured included the antibiotic use rate and the percentage of infants who were discharged without any exposure to antibiotics.
At the baseline of the quality initiative, the antibiotic use rate was 27.6% and it decreased to 15.5%, which was a 43% reduction in antibiotic use. The reduction was additionally maintained for >18 months. The investigators said that changes that had the biggest effect on this decrease included a 36-hour hard stop for antibiotics, a novel guideline for early-onset sepsis evaluation among infants <35 weeks, implementing a sepsis risk calculator, and adopting a 36-hour rule-out period for sepsis evaluation. During the quality initiative, the percent of infants who were discharged from the hospital without any exposure to antibiotics increased from 15.8% to 35.1%. Additionally, the perfect of infants ≥ 36 weeks who underwent an evaluation for early-onset sepsis decreased by 42.3% and among infants < 35 weeks, it went down by 26%.
The researchers involved in the quality initiative concluded that it had led to a significant reduction in both antibiotic use and exposure in their neonatal intensive care unit. They also believe that the comprehensive approach to the quality initiative could be useful to other teams that have a focus on improvement.
Reference
1. Meyers J, Tulloch J, Brown K, Caserta M, D’Angio C. A quality improvement initiative to optimize antibiotic use in a level 4 NICU. Pediatrics. October 14, 2020. Epub ahead of print. doi:10.1542/peds.2019-3956
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Higher pregnancy risks associated with maternal hidradenitis suppurativa
November 8th 2024A study of over 1 million births in Quebec reveals that pregnant women with hidradenitis suppurativa face increased risks of pregnancy complications and long-term health issues for both themselves and their offspring.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
